APA (7th ed.) Citation

LL, B., K, A., DM, R., MM, C., DA, K., & DN, F. (2025). Long-Term Efficacy and Safety of Mammalian Target of Rapamycin Inhibitor Treatment for Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis. Pediatric neurology, 168, 90. https://doi.org/10.1016/j.pediatrneurol.2025.04.007

Chicago Style (17th ed.) Citation

LL, Becker, Agricola K, Ritter DM, Caré MM, Krueger DA, and Franz DN. "Long-Term Efficacy and Safety of Mammalian Target of Rapamycin Inhibitor Treatment for Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis." Pediatric Neurology 168 (2025): 90. https://doi.org/10.1016/j.pediatrneurol.2025.04.007.

MLA (9th ed.) Citation

LL, Becker, et al. "Long-Term Efficacy and Safety of Mammalian Target of Rapamycin Inhibitor Treatment for Subependymal Giant Cell Astrocytoma in Tuberous Sclerosis." Pediatric Neurology, vol. 168, 2025, p. 90, https://doi.org/10.1016/j.pediatrneurol.2025.04.007.